Cell line · CVCL_7254
CT26
Cancer cell line, Mus musculus. Mouse colon adenocarcinoma. 88 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. CT26. Cell lines, record CVCL_7254. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_7254
On this page
Cell line
As Cellosaurus gives it.
- Name
- CT26
- Accession
- CVCL_7254
- RRID
- RRID:CVCL_7254
- Synonyms
- CT-26, CT 26, Colon Tumor 26
- Species
- Mus musculus (Mouse)
- Sex
- Female
- Category
- Cancer cell line
- Diseases
- Mouse colon adenocarcinoma (NCIt C120044)
- Derived from
- Colon (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers88
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| PubMed 42999633 | Immunotargets Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MAGI3 Acts as an Intestinal Epithelial Gatekeeper in Inflammation-Associated Colorectal Cancer by Suppressing the STAT3-CCL2 Axis and TAM-Mediated Immunosuppression. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| In-vitro cytotoxic and pro-apoptotic effects of an Echinococcus granulosus antigen B nanoformulation on CT26 colorectal cancer cells. | Front Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MIIP Inhibits Colorectal Cancer Progression by Modulating Neutrophils Infiltration and Neutrophil Extracellular Trap Formation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| In situ APMV-4 vaccination primes systemic response to subtherapeutic dosing of aCTLA-4 in colorectal carcinoma. | J Immunother Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment. | J Exp Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GPR39 Suppresses Ferroptosis via the Nrf2/SLC7A11 Axis and Reduces the Sensitivity of Colorectal Cancer to Anti-PD-1 Immunotherapy. | Can J Gastroenterol Hepatol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dual-MEK Inhibitor Atebimetinib Displays Broad Activity in RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition and Resisting RAF Bypass. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mucosal-associated invariant T cells recognize a tumor-derived metabolite in the DNA synthesis pathway. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Temporal Immune and Metabolic Shifts Drive the Anti-Tumor Efficacy of Resiquimod-Loaded Nanoparticles in Peritoneal Carcinomatosis. | Adv Healthc Mater | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 88
See all 88 papersRelatives20
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | CT26-PD-L1 KO | CVCL_B7NN | Cell lines | |
| Derived from it | CT26-hCD39-LZ | CVCL_E8GY | Cell lines | |
| Derived from it | CT26-hEpCam-LZ | CVCL_E8GZ | Cell lines | |
| Derived from it | CT26.WT | CVCL_7256 | Cell lines | |
| Derived from it | CT26/Cas9-hyg | CVCL_C9FK | Cell lines | |
| Derived from it | HyCyte CT26 KO-mAtm | CVCL_F1NN | Cell lines | |
| Derived from it | HyCyte CT26 KO-mCd274 | CVCL_E1JP | Cell lines | |
| Derived from it | HyCyte CT26 KO-mChst7 | CVCL_F4G9 | Cell lines | |
| Derived from it | HyCyte CT26 KO-mF3 | CVCL_F4JC | Cell lines | |
| Derived from it | HyCyte CT26 KO-mFgl2 | CVCL_F4HR | Cell lines |
1 to 10 of 20
See all 20 relativesCell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ABM | T8267 | ABM | |
| CLS | 305229 | CLS | |
| KCB | KCB 2012007YJ | Cellosaurus | |
| KCLB | 80009 | KCLB | |
| NCBI_Iran | C532 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_7254
GET https://conductscience.org/api/cell-lines/v1/CVCL_7254/papers?page=2